{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T06:12:40Z","timestamp":1770358360978,"version":"3.49.0"},"reference-count":67,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Costimulatory blockade\u2013induced allograft tolerance has been achieved in rodent models, but these strategies do not translate well to nonhuman primate and clinical transplants. One confounder that may underlie this discrepancy is the greater ischemic inflammation imposed on the transplants. In mice, cardiac allografts subjected to prolonged cold ischemic storage (CIS) before transplant have increased ischemia\u2013reperfusion injury, which amplifies infiltrating endogenous memory CD8 T-cell activation within hours after transplantation to mediate acute graft inflammation and cytotoxic lymphocyte-associated molecule-4 immunoglobulin\u2013resistant rejection. This study tested strategies inhibiting memory CD8 T-cell activation within such high ischemic allografts to achieve long-term survival.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>A\/J (H-2<jats:sup>a<\/jats:sup>) hearts subjected to 0.5 or 8\u2009h of CIS were transplanted to C57BL\/6 (H-2<jats:sup>b<\/jats:sup>) recipients and treatment with peritransplant costimulatory blockade. At 60 d posttransplant, regulatory T cells (Treg) were depleted in recipients of high ischemic allografts with anti-CD25 monoclonal antibody (mAb) or diphtheria toxin.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Whereas peritransplant (days 0 and +1) anti\u2013lymphocyte function-associated antigen-1 mAb and anti-CD154 mAb prolonged survival of &gt;60% allografts subjected to minimal CIS for &gt;100 d, only 20% of allografts subjected to prolonged CIS survived beyond day 80 posttransplant and rejection was accompanied by high titers of donor-specific antibody. Peritransplant anti\u2013lymphocyte function-associated antigen-1, anti\u2013tumor necrosis factor-\u03b1, and anti-CD154 mAb plus additional anti-CD154 mAb on days 14 and 16 obviated this donor-specific antibody and promoted Treg-mediated tolerance and survival of 60% of high ischemic allografts beyond day 100 posttransplant, but all allografts failed by day 120.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>These studies indicate a strategy inducing prolonged high ischemic allograft survival through Treg-mediated tolerance that is not sustained indefinitely.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000004570","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T04:01:27Z","timestamp":1680062487000},"page":"1935-1944","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Failure of Costimulatory Blockade-induced Regulatory T Cells to Sustain Long-term Survival of High Ischemic Allografts"],"prefix":"10.1097","volume":"107","author":[{"given":"Naoki","family":"Kohei","sequence":"first","affiliation":[{"name":"Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH."},{"name":"Department of Urology, Tokyo Women\u2019s Medical University, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH."},{"name":"Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Miyairi","sequence":"additional","affiliation":[{"name":"Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH."},{"name":"Department of Urology, Tokyo Women\u2019s Medical University, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetoshi","family":"Tsuda","sequence":"additional","affiliation":[{"name":"Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH."},{"name":"Department of Urology, Osaka University School of Medicine, Osaka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyofumi","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH."},{"name":"Department of Urology, Osaka University School of Medicine, Osaka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles A.","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH."},{"name":"Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle D.","family":"Kish","sequence":"additional","affiliation":[{"name":"Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunari","family":"Tanabe","sequence":"additional","affiliation":[{"name":"Department of Urology, Tokyo Women\u2019s Medical University, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Valujskikh","sequence":"additional","affiliation":[{"name":"Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Booki","family":"Min","sequence":"additional","affiliation":[{"name":"Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert L.","family":"Fairchild","sequence":"additional","affiliation":[{"name":"Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH."},{"name":"Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,8,21]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/ajt.15672","article-title":"OPTIN\/SRTR 2018 annual data report: kidney.","volume":"20","author":"Hart","year":"2018","journal-title":"Am J Transplant"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/01.tp.0000287117.98785.54","article-title":"Steroid-free maintenance immunosuppression with rapamune and low-dose oral in pancreas transplant recipients.","volume":"84","author":"Rajab","year":"2007","journal-title":"Transplantation"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1111\/ajt.14746","article-title":"Carpe diem\u2014time to transition from empiric to precision medicine in kidney transplantation.","volume":"18","author":"Wiebe","year":"2018","journal-title":"Am J Transplant"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1097\/TP.0000000000001648","article-title":"Clinical trials for immunosuppression in transplantation: the case for reform and changes in direction.","volume":"101","author":"O\u2019Connell","year":"2017","journal-title":"Transplantation"},{"key":"R5-20250604","first-page":"1730","article-title":"Comparison of the effects of standard vs low-dose prolonged-release tacrolimus with or without ACEi\/ARB on the histology and function of renal allografts.","volume":"18","author":"Cockfield","year":"2018","journal-title":"Am J Transplant"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/01.tp.0000275423.69689.dc","article-title":"Immunosuppression of the elderly kidney transplant recipient.","volume":"84","author":"Danovitch","year":"2007","journal-title":"Transplantation"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation.","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Eng J Med"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1600-6143.2008.02519.x","article-title":"Identifying specific causes of kidney allograft loss.","volume":"9","author":"Zoghby","year":"2009","journal-title":"Am J Transplant"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1111\/j.1600-6143.2005.00958.x","article-title":"Pre-transplant IFN-gamma ELISPOTs are associated with post-transplant renal function in African American renal transplant recipients.","volume":"5","author":"Augustine","year":"2005","journal-title":"Am J Transplant"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.4049\/jimmunol.163.4.2267","article-title":"Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of post-transplant rejection episodes.","volume":"163","author":"Heeger","year":"1999","journal-title":"J Immunol"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1034\/j.1600-6143.2003.00132.x","article-title":"Enzyme linked immunosorbent spot (ELISPOT) assay for interferon-gamma independently predicts renal function in kidney transplant recipients.","volume":"3","author":"Hricik","year":"2003","journal-title":"Am J Transplant"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1097\/01.TP.0000144057.31799.6A","article-title":"Enzyme-linked immunosorbent spot assay for donor-reactive interferon-gamma-producing cells identifies T-cell presensitization and correlates with graft function at 6 and 12 months in renal-transplant recipients.","volume":"78","author":"Nickel","year":"2004","journal-title":"Transplantation"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1681\/ASN.2007050539","article-title":"Circulating alloreactive T cells correlate with graft function in longstanding renal transplant recipients.","volume":"19","author":"Bestard","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"e0200696","DOI":"10.1371\/journal.pone.0200696","article-title":"Impact of preformed T-cell alloreactivity by means of donor-specific and panel of reactive T cells (PRT) ELISPOT in kidney transplantation.","volume":"13","author":"Gandolfini","year":"2018","journal-title":"PLoS One"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1172\/JCI200317477","article-title":"Heterologous immunity provides a potent barrier to transplantation tolerance.","volume":"111","author":"Adams","year":"2003","journal-title":"J Clin Invest"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1182\/blood-2009-07-234906","article-title":"Allo-HLA reactivity of virus-specific memory T cells is common.","volume":"115","author":"Amir","year":"2010","journal-title":"Blood"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"e71221","DOI":"10.1371\/journal.pone.0071221","article-title":"Heterologous immunity triggered by a single, latent virus in Mus musculus: combined costimulation- and adhesion-blockade decrease rejection.","volume":"8","author":"Beus","year":"2013","journal-title":"PLoS One"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1128\/JVI.74.5.2210-2218.2000","article-title":"Virus-induced abrogation of transplantation tolerance induced by donor-specific transfusion and anti-CD154 antibody.","volume":"74","author":"Welsh","year":"2000","journal-title":"J Virol"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.4049\/jimmunol.169.7.3686","article-title":"T cells primed by Leishmania major infection cross-react with alloantigens and alter the course of allograft rejection.","volume":"169","author":"Pantenburg","year":"2002","journal-title":"J Immunol"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1172\/JCI117630","article-title":"Chemokine expression during hepatic ischemia\/reperfusion-induced lung injury in the rat. The role of epithelial neutrophil activating protein.","volume":"95","author":"Colletti","year":"1995","journal-title":"J Clin Invest"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/00007890-200104150-00032","article-title":"Apoptosis and chemokine induction after renal ischemia-reperfusion.","volume":"71","author":"Daemen","year":"2001","journal-title":"Transplantation"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/nm.2507","article-title":"Ischemia and reperfusion-from mechanisms to translation.","volume":"17","author":"Eltzschig","year":"2011","journal-title":"Nat Med"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/00007890-199710150-00001","article-title":"Effects of initial ischemia\/reperfusion injury on the transplanted kidney.","volume":"64","author":"Tilney","year":"1997","journal-title":"Transplantation"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/TP.0000000000000072","article-title":"Mechanisms and consequences of injury and repair in older organ transplants.","volume":"97","author":"Slegtenhorst","year":"2014","journal-title":"Transplantation"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1161\/CIRCULATIONAHA.104.516708","article-title":"Inhibition of polymorphonuclear leukocyte-mediated graft damage synergizes with short-term costimulatory blockade to prevent cardiac allograft rejection.","volume":"112","author":"El-Sawy","year":"2005","journal-title":"Circulation"},{"key":"R26-20250604","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0002-9440(10)63283-X","article-title":"Early T cell response to allografts occurring prior to alloantigen priming up-regulates innate mediated inflammation and graft necrosis.","volume":"165","author":"El-Sawy","year":"2004","journal-title":"Am J Pathol"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1111\/j.1600-6143.2008.02302.x","article-title":"Donor-reactive CD8 memory T cells infiltrate cardiac allografts within 24-h posttransplant in naive recipients.","volume":"8","author":"Schenk","year":"2008","journal-title":"Am J Transplant"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.4049\/jimmunol.174.6.3741","article-title":"Alloreactive T cell responses and acute rejection of single class II MHC-disparate heart allografts are under strict regulation by CD4+CD25+ T cells.","volume":"174","author":"Schenk","year":"2005","journal-title":"J Immunol"},{"key":"R29-20250604","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1111\/ajt.12372","article-title":"Endogenous memory CD8 T cells are activated within cardiac allografts without mediating rejection.","volume":"13","author":"Setoguchi","year":"2013","journal-title":"Am J Transplant"},{"key":"R30-20250604","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/ajt.12605","article-title":"Endogenous memory CD8 T cells directly mediate cardiac allograft rejection.","volume":"14","author":"Su","year":"2014","journal-title":"Am J Transplant"},{"key":"R31-20250604","doi-asserted-by":"crossref","first-page":"e96940","DOI":"10.1172\/jci.insight.96940","article-title":"Allograft dendritic cell p40 homodimers activate donor-reactive memory CD8+ T cells.","volume":"3","author":"Tsuda","year":"2018","journal-title":"JCI Insight"},{"key":"R32-20250604","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/381434a0","article-title":"Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways.","volume":"381","author":"Larsen","year":"1996","journal-title":"Nature"},{"key":"R33-20250604","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1681\/ASN.2008040377","article-title":"Divergent role of donor dendritic cells in rejection versus tolerance of allografts.","volume":"20","author":"Ueno","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R34-20250604","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/j.1600-6143.2010.03066.x","article-title":"Infection with the intracellular bacterium, Listeria monocytogenes, overrides established tolerance in a mouse cardiac allograft model.","volume":"10","author":"Wang","year":"2010","journal-title":"Am J Transplant"},{"key":"R35-20250604","doi-asserted-by":"crossref","first-page":"786","DOI":"10.4049\/jimmunol.179.2.786","article-title":"A novel alloantigen-specific CD8+PD1+ regulatory T cell induced by ICOS-B7h blockade in vivo.","volume":"179","author":"Izawa","year":"2007","journal-title":"J Immunol"},{"key":"R36-20250604","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1600-6143.2005.00749.x","article-title":"Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA-4Ig with potent immunosuppressive properties.","volume":"5","author":"Larsen","year":"2005","journal-title":"Am J Transplant"},{"key":"R37-20250604","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/ajt.13100","article-title":"A pilot trial targeting the ICOS-ICOS-L pathway in nonhuman primate kidney transplantation.","volume":"15","author":"Lo","year":"2015","journal-title":"Am J Transplant"},{"key":"R38-20250604","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/ajt.14141","article-title":"Selective targeting of high-affinity LFA-1 does not augment costimulation blockade in a nonhuman primate renal transplantation model.","volume":"17","author":"Samy","year":"2017","journal-title":"Am J Transplant"},{"key":"R39-20250604","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-6143.2009.03005.x","article-title":"A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT Study).","volume":"10","author":"Vincenti","year":"2010","journal-title":"Am J Transplant"},{"key":"R40-20250604","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/TP.0000000000001004","article-title":"An acute cellular rejection with detrimental outcome occurring under belatacept-based immunosuppressive therapy: an immunological analysis.","volume":"100","author":"de Graav","year":"2016","journal-title":"Transplantation"},{"key":"R41-20250604","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJMoa1506027","article-title":"Belatacept and long-term outcomes in kidney transplantation.","volume":"374","author":"Vincenti","year":"2016","journal-title":"N Eng J Med"},{"key":"R42-20250604","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00007890-197310000-00010","article-title":"Primarily vascularized allografts of hearts in mice.","volume":"16","author":"Corry","year":"1973","journal-title":"Transplantation"},{"key":"R43-20250604","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1111\/j.1600-6143.2012.04073.x","article-title":"Antibody-mediated rejection of single class I MHC-disparate cardiac allografts.","volume":"12","author":"Hattori","year":"2012","journal-title":"Am J Transplant"},{"key":"R44-20250604","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/j.1600-6143.2011.03492.x","article-title":"LFA-1 antagonism inhibits early infiltration of endogenous memory CD8 T cells into cardiac allografts and donor-reactive T cell priming.","volume":"11","author":"Setoguchi","year":"2011","journal-title":"Am J Transplant"},{"key":"R45-20250604","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1111\/ajt.13150","article-title":"Anti-huCD20 antibody therapy for antibody-mediated rejection of renal allografts in a mouse model.","volume":"15","author":"Abe","year":"2015","journal-title":"Am J Transplant"},{"key":"R46-20250604","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.4049\/jimmunol.179.8.5238","article-title":"Antibody-mediated rejection of cardiac allografts in CCR5-deficient recipients.","volume":"179","author":"Nozaki","year":"2007","journal-title":"J Immunol"},{"key":"R47-20250604","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/01.TP.0000048377.59350.E4","article-title":"T-cell mediated induction of allogeneic endothelial cell chemokine expression.","volume":"75","author":"Kobayashi","year":"2003","journal-title":"Transplantation"},{"key":"R48-20250604","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1056\/NEJMoa071074","article-title":"HLA-mismatched renal transplantation without maintenance immunosuppression.","volume":"358","author":"Kawai","year":"2008","journal-title":"N Eng J Med"},{"key":"R49-20250604","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/TP.0000000000001559","article-title":"Effect of ex vivo-expanded recipient regulatory T cells on hematopoietic chimerism and kidney allograft tolerance across MHC barriers in Cynomolgus macaques.","volume":"101","author":"Duran-Struck","year":"2017","journal-title":"Transplantation"},{"key":"R50-20250604","first-page":"124","article-title":"Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation.","volume":"4","author":"Levanthal","year":"2012","journal-title":"Sci Transl Med"},{"key":"R51-20250604","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/74731","article-title":"Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment.","volume":"6","author":"Wekerle","year":"1998","journal-title":"Nat Med"},{"key":"R52-20250604","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4049\/jimmunol.165.1.1","article-title":"Administration of anti-CD40 ligand and donor bone marrow leads to hematopoietic chimerism and donor-specific tolerance without cytoreductive conditioning.","volume":"165","author":"Durham","year":"2000","journal-title":"J Immunol"},{"key":"R53-20250604","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1056\/NEJMc1213779","article-title":"HLA-mismatched renal transplantation without maintenance immunosuppression.","volume":"368","author":"Kawai","year":"2013","journal-title":"N Eng J Med"},{"key":"R54-20250604","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1172\/JCI70084","article-title":"B cells mediate chronic allograft rejection independently of antibody production.","volume":"124","author":"Zheng","year":"2014","journal-title":"J Clin Invest"},{"key":"R55-20250604","doi-asserted-by":"crossref","first-page":"e125489","DOI":"10.1172\/jci.insight.125489","article-title":"Interleukin-27 promotes CD8+ T cell reconstitution following antibody-mediated lymphoablation.","volume":"4","author":"Ayasoufi","year":"2019","journal-title":"JCI Insight"},{"key":"R56-20250604","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1111\/ajt.15960","article-title":"B cell derived IL-1\u03b2 and IL-6 drive T cell reconstitution following lymphoablation.","volume":"20","author":"Hasgur","year":"2020","journal-title":"Am J Transplant"},{"key":"R57-20250604","doi-asserted-by":"crossref","first-page":"20701","DOI":"10.1073\/pnas.1105500108","article-title":"Antigen-specific induced Foxp3+ regulatory T cells are generated following CD40\/CD154 blockade.","volume":"108","author":"Ferrer","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"R58-20250604","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1097\/TP.0000000000001482","article-title":"In vivo costimulation. Blockade-induced regulatory T cells demonstrate dominant and specific tolerance to porcine islet xenografts.","volume":"101","author":"Wu","year":"2017","journal-title":"Transplantation"},{"key":"R59-20250604","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1097\/TP.0000000000002740","article-title":"Selective costimulation blockade with anti-CD28 therapeutics in transplantation.","volume":"103","author":"Vanhove","year":"2019","journal-title":"Transplantation"},{"key":"R60-20250604","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.4049\/jimmunol.181.2.1034","article-title":"Contribution of regulatory T cells and effector T cell deletion in tolerance induction by costimulation blockade.","volume":"181","author":"Verbinnen","year":"2008","journal-title":"J Immunol"},{"key":"R61-20250604","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1097\/TP.0000000000003509","article-title":"Unraveling the crucial roles of FoxP3+ regulatory T cells in vascularized composite allograft tolerance induction and maintenance.","volume":"105","author":"Anggelia","year":"2021","journal-title":"Transplantation"},{"key":"R62-20250604","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/art.10856","article-title":"A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis.","volume":"48","author":"Boumpas","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R63-20250604","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/01.TP.0000110291.29370.C0","article-title":"Thrombophilia associated with anti-CD154 monolconal antibody treatment and its prophylaxis in nonhuman primates.","volume":"77","author":"Koyama","year":"2004","journal-title":"Transplantation"},{"key":"R64-20250604","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00007890-200102150-00028","article-title":"Anti-CD154 monoclonal antibody and thromboembolism.","volume":"71","author":"Buhler","year":"2001","journal-title":"Transplantation"},{"key":"R65-20250604","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/ajt.15661","article-title":"First-in-human clinical trial to assess pharmacokinetics, pharmacodynamics, safety, and tolerability of iscalimab, an anti-CD40 monoclonal antibody.","volume":"20","author":"Espie","year":"2019","journal-title":"Am J Transplant"},{"key":"R66-20250604","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/ajt.14197","article-title":"Fc-silent anti-CD154 domain antibody effectively prevents nonhuman primate renal allograft rejection.","volume":"17","author":"Kim","year":"2017","journal-title":"Am J Transplant"},{"key":"R67-20250604","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1111\/ajt.13377","article-title":"A novel, blocking Fc-silent anti-CD40 monoclonal antibody prolongs nonhuman primate renal allograft survival in the absence of B cell depletion.","volume":"15","author":"Cordoba","year":"2015","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004570","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:11:12Z","timestamp":1749060672000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,21]]},"references-count":67,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000004570","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,21]]}}}